Causes and Management of Vasovagal Syncope
Vasovagal syncope is primarily managed through education, lifestyle modifications, and physical counterpressure maneuvers, with pharmacological and device therapies reserved for severe or refractory cases. 1
Causes of Vasovagal Syncope
Vasovagal syncope is a type of neurally-mediated reflex syncope characterized by:
Triggered reflex response leading to vasodilatation and bradycardia, resulting in systemic hypotension and cerebral hypoperfusion 2
Classical triggers include:
Vasodilator medications may enhance susceptibility 2
Initial Assessment and Management
Careful history is crucial to distinguish vasovagal syncope from other causes of transient loss of consciousness 2
Warning signs that suggest potentially life-threatening causes rather than benign vasovagal syncope include:
Initial treatment for most patients should focus on education and reassurance about the benign nature of vasovagal syncope 2, 1
Treatment is not necessary for patients who have experienced only a single episode and are not in a high-risk setting 2
Treatment Indications
Additional treatment may be necessary when:
- Syncope is very frequent and affects quality of life 2
- Episodes are recurrent and unpredictable (absence of premonitory symptoms) with high risk of trauma 2
- Syncope occurs during high-risk activities (driving, machine operation, flying, competitive athletics) 2
Non-Pharmacological Management (First-Line)
Class I recommendations (evidence/general agreement of benefit):
Class II recommendations (conflicting evidence but favorable):
- Volume expansion through increased salt intake and fluids (2-2.5 liters daily) 2, 1
- Exercise program to improve cardiovascular tone 2, 1
- Sleeping with head elevated >10° for posture-related syncope 2, 1
- Tilt training (progressively prolonged periods of upright posture) in motivated patients 2
- Isometric leg and arm counter-pressure maneuvers during prodromal symptoms 2, 1
Pharmacological Management
Class III recommendation (evidence against efficacy):
Other pharmacological options (for refractory cases):
Device Therapy
- Cardiac pacing should be considered in specific cases:
- Patients with cardioinhibitory or mixed carotid sinus syndrome 2
- Patients with cardioinhibitory vasovagal syncope with >5 attacks per year or severe physical injury, and age >40 2
- Evidence shows syncope recurred in 21% of paced patients versus 44% of non-paced patients 2
- However, pacing should be reserved for cases that have failed alternative therapies 1, 3
Special Considerations
- Pediatric patients: Syncope in childhood is common and usually benign 2
- Elderly patients: Atypical presentation is common with short or absent prodrome, and may be misdiagnosed as falls 5
- High-risk occupations: More aggressive treatment approaches may be warranted 1